Evidence map›Paper›PMID 39835568›Full record

ArticleCurrent pediatric reviews2026

Outcome of Pediatric, Adolescent, and Young Adult Oncology Patients With Non-neutropenic Fever: A Scoping Review of the Literature.

Annabelle Wagner, Yeliz Akarsu, Marc Remke, Dominik Schoendorf, Johannes Huebner, Thomas Lehrnbecher, Markus Hufnagel, Konrad Bochennek, Arne Simon

Abstract readScoping Review
PubMed Publisher
In one paragraph

Article in Current pediatric reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Annabelle WagnerDepartment of Pediatric Hematology and Oncology, University Medical Center of Saarland, Kirrberger Straße, Building 9, 66421, Homburg/Saar, Germany.ORCID 0000-0002-8460-8317
Yeliz AkarsuDepartment of Pediatric Hematology and Oncology, University Medical Center of Saarland, Kirrberger Straße, Building 9, 66421, Homburg/Saar, Germany.
Marc RemkeDepartment of Pediatric Hematology and Oncology, University Medical Center of Saarland, Kirrberger Straße, Building 9, 66421, Homburg/Saar, Germany.ORCID 0000-0002-9404-9993
Dominik SchoendorfDepartment of Pediatric Hematology and Oncology, University Medical Center of Saarland, Kirrberger Straße, Building 9, 66421, Homburg/Saar, Germany.ORCID 0000-0002-0174-4269
Johannes HuebnerDepartment of Pediatric Infectious Diseases, Ludwig-Maximilians- University Munich, Dr. von Haunersches Kinderspital, Lindwurmstraße 4, 80337, Munich, Germany.ORCID 0000-0003-1232-4646
Thomas LehrnbecherDepartment of Pediatrics, Department of Pediatric Hematology and Oncology, Johann Wolfgang Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.ORCID 0000-0002-6022-3439
Markus HufnagelDepartment of Pediatric Infectious Diseases and Rheumatology, Department of General Pediatrics and Adolescent Medicine, University Medical Center Freiburg, Mathildenstraße 1, 79106, Freiburg, Germany.
Konrad BochennekDepartment of Pediatrics, Department of Pediatric Hematology and Oncology, Johann Wolfgang Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt am Main, Germany.ORCID 0000-0002-6881-6511
Arne SimonDepartment of Pediatric Hematology and Oncology, University Medical Center of Saarland, Kirrberger Straße, Building 9, 66421, Homburg/Saar, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are established guidelines for pediatric oncology patients with neutropenic fever. However, half of pediatric oncology patients present with non-neutropenic fever. For this group, no established guidelines exist.

objectiveIn this scoping review, we have explored the outcomes of non-neutropenic fever in pediatric, adolescent, and young adult patients with cancer-directed treatment. The results of this scoping review should assist in the creation of a guideline for the management of non-neutropenic fever in this group of patients.

methodsMultiple electronic databases and reference lists were searched (PubMed, MEDLINE CENTRAL, and Google (first 100 results only)). Included are retrospective and prospective cohort studies on the management and outcome of pediatric oncology patients with non-neutropenic fever that have been published after the year 2000.

resultsSeventeen studies with a total of 10.845 fever episodes were included, that address the treatment and outcome of patients with non-neutropenic fever. The rate of bacteremia was 1.6 - 14.4% (mean 5.8%). The mortality rate was low and due to non-bacterial causes. Across different studies, proposed risk factors for bacteremia were higher temperature, prolonged fever over 72 hours, ill-appearing patients, chills, hypotension, leukocytosis, infancy, and the presence of a Broivac/ Hickman catheter. Limitations to this study are the risk of bias and potential incomplete identification of relevant studies pertinent to the research questions asked.

conclusionDue to significant heterogeneity, the published data so far are not sufficient to propose evidence-based guidelines for pediatric oncology patients with non-neutropenic fever. Prospective, multicenter registries based on uniform definitions are needed. No funding was received for this manuscript.

Indexed as

FeverNeoplasmsAdolescentBacteremiaChildHumansYoung Adultbacteremiaimmunocompromised patientsindwelling catheterinfectionsNon-neutropenic fever OR fever without neutropeniapediatric cancer OR pediatric oncology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.